Advanced search
Publication Cover
Journal of Pain Research Volume 16, 2023 - Issue
Submit an article Journal homepage
185
Views
0
CrossRef citations to date
0
Altmetric
Cancer Pain and Palliative Care

Evaluation of Gabapentin as a Treatment of Breakthrough Cancer Pain Caused by Metastatic Prostate Adenocarcinoma

Jufriady Ismy1 Department of Urology, Faculty of Medicine, Universitas Syiah Kuala/Dr. Zainoel Abidin General Hospital, Aceh, IndonesiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4462-7433View further author information
ORCID Icon,
Dessy R Emril2 Department of Neurology, Faculty of Medicine, Universitas Syiah Kuala/Dr. Zainoel Abidin General Hospital, Aceh, IndonesiaView further author information
,
Said Alfin Khalilullah1 Department of Urology, Faculty of Medicine, Universitas Syiah Kuala/Dr. Zainoel Abidin General Hospital, Aceh, IndonesiaORCID Iconhttps://orcid.org/0000-0002-1517-5917View further author information
ORCID Icon &
Muhammad Puteh Mauny1 Department of Urology, Faculty of Medicine, Universitas Syiah Kuala/Dr. Zainoel Abidin General Hospital, Aceh, IndonesiaView further author information
Pages 3319-3324 | Received 09 Jun 2023, Accepted 25 Sep 2023, Published online: 02 Oct 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Ministry of Health RI. Results of basic health research in 2018. Ministry Health Republic Indonesia. 2018;53.
  • Sofyan HR. The prevalence of neuropathic pain in patients with cancer pain at the Hospital Dr. Cipto Mangunkusumo and PKN RS Dharmais. Neurona. 2020;37(3):161–167.
  • Jara C, Del Barco S, Grávalos C, et al. SEOM clinical guideline for treatment of cancer pain (2017). Clin Transl Oncol. 2018;20(1):97–107. doi:10.1007/s12094-017-1791-2
  • Pérez-Hernández C, Blasco A, Gándara Á, et al. Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study. Sci Rep. 2019;9(17701). doi:10.1038/s41598-019-54195-x
  • Davies AN, Elsner F, Filbet MJ, et al. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines. BMJ Support Palliat Care. 2018;8(3):241–249. doi:10.1136/bmjspcare-2017-001467
  • Smith DK, Cmelak A, Niermann K, et al. Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation. Head Neck. 2020;42(12):3497–3505. doi:10.1002/hed.26407
  • Bao H, Wu Z, Wang Q, et al. The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis. Transl Cancer Res. 2021;10(2):637–644. doi:10.21037/tcr-20-2692
  • Yoon SY, Oh J. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J Intern Med. 2018;33(6):1058–1069. doi:10.3904/kjim.2018.162
  • Rahmadi M, Madina U, Sulianto I, et al. Study on dosage range evaluation opioid analgesic for breakthrough pain in cancer patients: a retrospective study. Ann Palliat Med. 2021;10(2):1237–1243. doi:10.21037/apm-20-492
  • Munoz MC, Estevez FV, Lopez AJ, Alvarez AC, Lopez BS. Evaluation of quality of life and satisfaction of patients with neuropathic pain and breakthrough pain: economic impact based on quality of life. Pain Res Treat. 2018;2018:1–8. doi:10.1155/2018/5394021
  • Hjermstad MJ, Kaasa S, Caraceni A, et al. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Support Palliat Care. 2016;6(3):344–352. doi:10.1136/bmjspcare-2015-000887
  • Yang JY, Lee WI, Shin WK, Kim CH, Baik SW, Kim KH. Administration of four different doses of gabapentin reduces awakening from breakthrough pain and adverse effects in outpatients with neuropathic pain during the initial titration. Korean J Anesthesiol. 2013;65(1):48–54. doi:10.4097/kjae.2013.65.1.48
  • Mishra S, Bhatnagar S, Chaudhary P, Rana SP. Breakthrough cancer pain: review of prevalence, characteristics and management. Indian J Palliat Care. 2009;15(1):14–18. doi:10.4103/0973-1075.53506
  • Mercadante S, Caraceni A, Cuomo A, et al. A Longitudinal Study of Breakthrough Cancer Pain: an Extension of IOPS-MS Study. J Clin Med. 2021;10(11):2273. doi:10.3390/jcm10112273
  • Fornasari D. Pharmacotherapy for Neuropathic Pain: a Review. Pain Ther. 2017;6(Suppl 1):25–33. doi:10.1007/s40122-017-0091-4
  • Quintero GC. Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol. 2017;9:13–21. doi:10.2147/JEP.S124391

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.